论文信息 - Toll‐IL1 receptor‐mediated innate immune responses vary across HBV genotype and predict treatment response to pegylated‐IFN in HBeAg‐positive CHB patients - 字舞流文

Toll‐IL1 receptor‐mediated innate immune responses vary across HBV genotype and predict treatment response to pegylated‐IFN in HBeAg‐positive CHB patients

P. Revill | S. Ahn | E. Gane | A. Mansell | S. H. Ahn | K. Visvanathan | N. Skinner | A. Thompson | T. Lang | D. Colledge | A. Thompson | S. Locarnini | W. Abbott | F. Weilert | R. Wilson | K. Ryan | K. Li | N. A. Skinner | S. H. Ahn | P. A. Revill